Systemic and immune manifestations in myelodysplasia: A multicenter retrospective study

Arthritis Care and Research

Volumn 63, Issue 8, 2011, Pages 1188-1194

  De Hollanda, A ^a   Beucher, A ^a   Henrion, D ^a   Ghali, A ^a   Lavigne, C ^a   Levesque H ^b   Hamidou, M ^c   Subra, J F ^a   Ifrah, N ^a   Belizna, C ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; CORTICOSTEROID; CRYOGLOBULIN; CYTARABINE; LENALIDOMIDE;

AGED; ARTHRALGIA; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FEVER; HIGH RISK PATIENT; HUMAN; LEUKOCYTOCLASTIC VASCULITIS; LOW DRUG DOSE; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); MYELODYSPLASTIC SYNDROME; NEPHRITIS; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; PROGNOSIS; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; RETROSPECTIVE STUDY; SKIN MANIFESTATION; SURVIVAL RATE; SYSTEMIC DISEASE; THROMBOCYTE TRANSFUSION; THROMBUS;

AGED; AGED, 80 AND OVER; ARTHRALGIA; ARTHRITIS; CRYOGLOBULINS; FEMALE; FEVER; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RETROSPECTIVE STUDIES; SYSTEMIC VASCULITIS;

EID: 84860389167     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20504     Document Type: Article

References (27)

1. Naschitz JE, Rosner I, Rozenbaum M, Elias N, Yeshurun D. Cancer-associated rheumatic disorders. Semin Arthritis Rheum 1995;24:231-41.
2. Kurzrock R, Cohen PR. Mucocutaneous paraneoplastic manifestations of hematologic malignancies. Am J Med 1995;99:207-16.
3. Mufti GJ, Figes A, Hamblin TJ, Oscier DJ, Copplestone JA. Immunological abnormalities in myelodysplastic syndromes. Br J Haematol 1986;63:143-7.
4. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189-99. (Pubitemid 12073508)
5. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079-88. (Pubitemid 27132124)
6. WHO classification of tumours. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al, editors. WHO classification of tumours of hematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 109-38.
7. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009;114:937-51.
8. Okuse C, Yotsuyanagi H, Okazaki T, Yasuda K, Fujioka T, Tomoe M, et al. Detection, using a novel method, of a high prevalence of cryoglobulinemia in persistent hepatitis C virus infection. Hepatol Res 2003;27:18-22. (Pubitemid 37168647)
9. Hamblin T. Immunologic abnormalities in myelodysplastic syndromes. Hematol Oncol Clin North Am 1992;6:571-86.
10. Hamblin TJ. Immunological abnormalities in myelodysplastic syndromes. Semin Hematol 1996;33:150-62. (Pubitemid 26128722)
11. Enright H, Jacob HS, Vercellotti G, Howe R, Belzer M, Miller W. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematol 1995;91:403-8.
12. Castro M, Conn DL, Su WP, Garton JP. Rheumatic manifestations in myelodysplastic syndromes. J Rheumatol 1991;18:721-7.
13. Billstrom R, Johansson H, Johansson B, Mitelman F. Immunemediated complications in patients with myelodysplastic syndromes: clinical and cytogenetic features. Eur J Haematol 1995;55:42-8.
14. Aslangul-Castier E, Papo T, Amoura Z, Baud O, Leblond V, Charlotte F, et al. Systemic vasculitis with bilateral perirenal haemorrhage in chronic myelomonocytic leukaemia. Ann Rheum Dis 2000;59:390-3. (Pubitemid 30316787)
15. Philippe B, Couderc LJ, Droz D, Charlotte F, Choukroun G, Epardeau B, et al. Systemic vasculitis and myelodysplastic syndromes: a report of two cases. Arthritis Rheum 1997;40:179-82. (Pubitemid 27044050)
16. Hamidou MA, Boumalassa A, Larroche C, El Kouri D, Bletry O, Grolleau JY, et al. Systemic medium-sized vessel vasculitis associated with chronic myelomonocytic leukemia. Semin Arthritis Rheum 2001;31:119-26. (Pubitemid 32988971)
17. Saif MW, Hopkins JL, Gore SD. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Lymphoma 2002;43:2083-92. (Pubitemid 35174719)
18. George SW, Newman ED. Seronegative inflammatory arthritis in the myelodysplastic syndromes. Semin Arthritis Rheum 1992;21:345-54.
19. Diebold L, Rauh G, Jager K, Lohrs U. Bone marrow pathology in relapsing polychondritis: high frequency of myelodysplastic syndromes. Br J Haematol 1995;89:820-30.
20. Pirayesh A, Verbunt R, Kluin PH, Meinders AE, de Meijer P. Myelodysplastic syndrome with vasculitic manifestations. J Intern Med 1997;224:425-31. (Pubitemid 27513110)
21. Savige JA, Chang L, Smith CL, Duggan JC. Myelodysplasia, vasculitis and anti-neutrophil cytoplasm antibodies. Leuk Lymphoma 1993;9:49-54. (Pubitemid 23141039)
22. Giannouli S, Voulgarelis M, Zintzaras E, Tzioufas AG, Moutsopoulos HM. Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study. Rheumatology (Oxford) 2004;43:626-32. (Pubitemid 38628195)
23. Hamidou M, Derenne S, Audrain M, Berthelot JM, Boumalassa A, Grolleau JY. Prevalence of rheumatic manifestations and antineutrophil cytoplasmic antibodies in haematological malignancies: a prospective study. Rheumatology (Oxford) 2000;39:417-20. (Pubitemid 30307328)
24. Okamoto T, Okada M, Mori A, Saheki K, Takatsuka H, Wada H, et al. Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients. Int J Hematol 1997;66:345-51. (Pubitemid 27495992)
25. Heaney ML, Golde DW. Myelodysplasia. N Engl J Med 1999;340:1649-60. (Pubitemid 29249435)
26. Williamson PJ, Oscier DG, Bell AJ, Hamblin TJ. Red cell aplasia in myelodysplastic syndrome. J Clin Pathol 1991;44:431-2.
27. Giannouli S, Tzoanopoulos D, Ritis K, Kartalis G, Moutsopoulos HM, Voulgarelis M. Autoimmune manifestations in human myelodysplasia: a positive correlation with interferon regulatory factor-1 (IRF-1) expression. Ann Rheum Dis 2004;63:578-82. (Pubitemid 38530204)